OSR Holdings

OSRH · NASDAQ

$0.2099−$0.0001 (−0.05%)TodayMarket closed ·
Prev close $0.21

Latest news

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseACCESS Newswire

    OSR Health Sees Global Shareholder Momentum at Critical Inflection Point

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • Press releaseACCESS Newswire

    OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development

  • Press releaseACCESS Newswire

    OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program

  • Press releaseACCESS Newswire

    OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment

  • Press releaseACCESS Newswire

    OSR Health, A Message From the CEO

  • Press releaseACCESS Newswire

    CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

  • Press releaseACCESS Newswire

    Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

  • Press releaseACCESS Newswire

    OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseACCESS Newswire

    Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsMohd Haider

    OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releasePRNewswire

    Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releasePRNewswire

    Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

  • Press releasePRNewswire

    Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

  • Press releasePRNewswire

    Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

  • NewsAvi Kapoor

    Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

  • Press releasePRNewswire

    Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

  • Press releasePRNewswire

    Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

  • Press releasePRNewswire

    OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsAvi Kapoor

    Dow Surges Over 200 Points; BJ's Wholesale Posts Upbeat Q3 Earnings

  • Press releasePRNewswire

    Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

  • Press releasePRNewswire

    OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

  • Press releasePRNewswire

    OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releasePRNewswire

    OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

  • Press releasePRNewswire

    OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

  • NewsAvi Kapoor

    US Stocks Mixed; Dow Falls Over 150 Points

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.